TCT 612: First comconitant double transcatheter valve replacement in native anatomy using dedicated devices
We Recommend
Disclosures
Within the last 24 months, I have financial relationship(s) or affiliation(s) with a manufacturer, marketer, reseller, or distributor of a healthcare product or service involved in the management of patients with any cardiovascular disease to include devices, drugs, and digital health care products listed below:
- Grant Support/Research Contract (Institutional) - Abbott Vascular; Edwards Lifesciences
- Consultant Fee/Honoraria/Speaker's Bureau (Personal) - Cordis Corporation, a Johnson & Johnson company; Medtronic
- Salary/Salary Support/Employee (Personal) - Cedars-Sinai Medical Center